Glycorex signs Malaysia distribution deal with OneMedik for Glycosorb ABO

Reuters2026/08/27 12:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glycorex Transplantation entered a distribution agreement with Malaysia’s OneMedik for its Glycosorb ABO immunoadsorption device.
Deal expands access in Malaysia, a market where living-donor procedures account for about 70% of kidney transplants.
OneMedik will distribute the product to local healthcare providers, targeting transplantation use with potential expansion into transfusion medicine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glycorex Transplantation AB published the original content used to generate this news brief via Cision (Ref. ID: 20260827:BIT:3057:0) on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Glycorex signs Malaysia distribution deal with OneMedik for Glycosorb ABO

You may also like

Crypto prices